ACET vs CRMG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ACET Captures Institutional Edge (2โ2 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Adicet Bio, Inc. Common Stock (ACET) driven by superior Valuation, Growth & Margin while CRMG counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, ACET trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus CRMG at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ACET sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro) against CRMG sits in UNCLASSIFIED (39th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ACET | CRMG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $27.4M | N/A | Larger Scale | ACET |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -100.0% | N/A | Higher Growth | ACET |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | ACET |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | ACET |
| Return on Equity (ROE) Capital Efficiency | -78.1% | N/A | Higher ROE | ACET |
| 52-Week Range Position Momentum | 23% ($0โ$10) | 29% ($4โ$14) | Stronger Trend | CRMG |
| Beta / 30D Volatility Risk Regime | 1.87ฮฒ ยท 44% Vol | 0.46ฮฒ ยท 61% Vol | Lower Realized Risk | ACET |
| Unified Institutional Score Composite Signal | 43.8 / 100 (HOLD) | 63.5 / 100 (BUY) | Higher Composite | CRMG |